SuperworthSagimet Biosciences shares outstanding SGMT
Diluted shares outstanding, averaged over each quarter, from 2022.
- Latest quarter, to Jun 30, 2026
- 53.1M
- On a year earlier
- +65.0%
- more shares
Sagimet Biosciences had 53.1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 65.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 32.5M | +1% |
| FY2024 | 32.3M | +39% |
| FY2023 | 23.3M | +12551% |
| FY2022 | 184.2K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 53.1M | +65% | |
| Q1 FY26 | 32.6M | +1% | |
| Q4 FY25 | 32.5M | +1% | |
| Q3 FY25 | 32.5M | +1% | |
| Q2 FY25 | 32.2M | +1% | |
| Q1 FY25 | 32.2M | +11% | |
| Q4 FY24 | 32.3M | +39% | |
| Q3 FY24 | 32.1M | +77% | |
| Q2 FY24 | 31.9M | +16739% | |
| Q1 FY24 | 29M | +15585% | |
| Q4 FY23 | 23.3M | +12551% | |
| Q3 FY23 | 18.2M | +9730% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Sagimet Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.